annual cash & cash equivalents:
$771.74M+$431.29M(+126.68%)Summary
- As of today (May 29, 2025), NAMS annual cash & cash equivalents is $771.74 million, with the most recent change of +$431.29 million (+126.68%) on December 31, 2024.
- During the last 3 years, NAMS annual cash & cash equivalents has risen by +$711.63 million (+1183.84%).
- NAMS annual cash & cash equivalents is now at all-time high.
Performance
NAMS Cash and cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly cash & cash equivalents:
$748.42M-$23.32M(-3.02%)Summary
- As of today (May 29, 2025), NAMS quarterly cash & cash equivalents is $748.42 million, with the most recent change of -$23.32 million (-3.02%) on March 31, 2025.
- Over the past year, NAMS quarterly cash & cash equivalents has increased by +$267.27 million (+55.55%).
- NAMS quarterly cash & cash equivalents is now -3.02% below its all-time high of $771.74 million, reached on December 31, 2024.
Performance
NAMS quarterly cash & cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and cash equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
NAMS Cash and cash equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +126.7% | +55.5% |
| 3 y3 years | +1183.8% | +700.7% |
| 5 y5 years | +7881.9% | +1145.0% |
NAMS Cash and cash equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +1183.8% | -3.0% | +1145.0% |
| 5 y | 5-year | at high | +7881.9% | -3.0% | +1145.0% |
| alltime | all time | at high | +7881.9% | -3.0% | +1145.0% |
NAMS Cash and cash equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $748.42M(-3.0%) |
| Dec 2024 | $771.74M(+126.7%) | $771.74M(+82.6%) |
| Sep 2024 | - | $422.73M(-1.9%) |
| Jun 2024 | - | $430.71M(-10.5%) |
| Mar 2024 | - | $481.15M(+41.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2023 | $340.45M(-27.2%) | $340.45M(-18.3%) |
| Jun 2023 | - | $416.76M(-10.9%) |
| Dec 2022 | $467.73M(+678.1%) | $467.73M(+400.4%) |
| Jun 2022 | - | $93.47M(+55.5%) |
| Dec 2021 | $60.11M(+521.7%) | $60.11M |
| Dec 2020 | $9.67M | - |
FAQ
- What is NewAmsterdam Pharma Company NV annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for NewAmsterdam Pharma Company NV?
- What is NewAmsterdam Pharma Company NV annual cash & cash equivalents year-on-year change?
- What is NewAmsterdam Pharma Company NV quarterly cash & cash equivalents?
- What is the all time high quarterly cash & cash equivalents for NewAmsterdam Pharma Company NV?
- What is NewAmsterdam Pharma Company NV quarterly cash & cash equivalents year-on-year change?
What is NewAmsterdam Pharma Company NV annual cash & cash equivalents?
The current annual cash & cash equivalents of NAMS is $771.74M
What is the all time high annual cash & cash equivalents for NewAmsterdam Pharma Company NV?
NewAmsterdam Pharma Company NV all-time high annual cash & cash equivalents is $771.74M
What is NewAmsterdam Pharma Company NV annual cash & cash equivalents year-on-year change?
Over the past year, NAMS annual cash & cash equivalents has changed by +$431.29M (+126.68%)
What is NewAmsterdam Pharma Company NV quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of NAMS is $748.42M
What is the all time high quarterly cash & cash equivalents for NewAmsterdam Pharma Company NV?
NewAmsterdam Pharma Company NV all-time high quarterly cash & cash equivalents is $771.74M
What is NewAmsterdam Pharma Company NV quarterly cash & cash equivalents year-on-year change?
Over the past year, NAMS quarterly cash & cash equivalents has changed by +$267.27M (+55.55%)